CIPROFLOXACIN TEVA 250 MG
Country: Iżrael
Lingwa: Ingliż
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
CIPROFLOXACIN AS HYDROCHLORIDE
Disponibbli minn:
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
Kodiċi ATC:
S03AA07
Għamla farmaċewtika:
TABLETS
Kompożizzjoni:
CIPROFLOXACIN AS HYDROCHLORIDE 250 MG
Rotta amministrattiva:
PER OS
Tip ta 'preskrizzjoni:
Required
Manifatturat minn:
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
Grupp terapewtiku:
CIPROFLOXACIN
Żona terapewtika:
CIPROFLOXACIN
Indikazzjonijiet terapewtiċi:
Broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. Treatment of acute pulmonary exacerbation of cystic fibrosis associated with P. aeruginosa infections in pediatric patients aged 5-17 years.
Data ta 'l-awtorizzazzjoni:
2012-03-31
